BACK UP
|
FOOTER
B-CELLS ARE HEROES OF OUR IMMUNE SYSTEM
WE TURN THEM INTO SUPERHEROES
IN THEIR BATTLE AGAINST THREATS, B-CELLS ROLL THE DICE TO GENERATE THE RIGHT ANTIBODY.
WE THINK SOME DISEASES ARE TOO DANGEROUS TO LEAVE THE DEFENCE AGAINST THEM UP TO CHANCE
WE PROPOSE A NOVEL THERAPY: B-CELLS THAT ARE ENGINEERED TO EXPRESS ANTIBODIES AGAINST A SPECIFIC TARGET...
SUCH AS CANCER ANTIGENS, WHERE OUR BEE-CELLS BOOST LOCAL IMMUNITY AND PREVENT RELAPSE FOR LIFE
CHRONIC VIRAL INFECTIONS, WHERE OUR BEE CELLS UNDERGO CLASS SWITCHING AND SOMATIC HYPERMUTATION TO COMBAT RAPIDLY MUTATING VIRUSES
ACUTE MRSA BACTERIAL INFECTIONS, WHERE OUR BEE-CELLS OFFER PROPHYLACTIC PROTECTION FOR HIGH-RISK PATIENTS
NEURODEGENERATIVE DISEASES, WHERE OUR BEE-CELLS IDENTIFY AND RESOLVE THREATS BEFORE SYMPTOMS OCCUR
WE INTRODUCE CUSTOM ANTIBODIES INTO THE ENDOGENOUS LOCUS, MAKING OUR APPROACH APPLICABLE TO ANY TARGET
COMPATIBLE WITH ADDITIONAL BINDING DOMAINS: OUR BBB-SHUTTLE, LINKED ANTIBODY CHAINS FOR SIMPLFIED ENGENEERING OR ANTIBODY DERIVATES
WITH GREAT POWER COMES GREAT RESPONSIBILITY. THAT’S WHY OUR PLATFORM COMES WITH ADDITIONAL SAFETY FEATURES
FOR THIS WE IMPLEMENT A CASCADE SAFETY MECHANISM: KILL SWITCH, DEPLETION FACTOR, MODULATION SWITCH, AND OVER-EXPRESSION MARKER
EXPLORE THIS WIKI TO LEARN HOW WE PLAN TO MAKE THESE SKETCHES REALITY.
B-CELLS ARE HEROES OF OUR IMMUNE SYSTEM
WE TURN THEM INTO SUPERHEROES
IN THEIR BATTLE AGAINST THREATS, B-CELLS ROLL THE DICE TO GENERATE THE RIGHT ANTIBODY.
WE THINK SOME DISEASES ARE TOO DANGEROUS TO LEAVE THE DEFENCE AGAINST THEM UP TO CHANCE
WE PROPOSE A NOVEL THERAPY: B-CELLS THAT ARE ENGINEERED TO EXPRESS ANTIBODIES AGAINST A SPECIFIC TARGET...
SUCH AS CANCER ANTIGENS, WHERE OUR BEE-CELLS BOOST LOCAL IMMUNITY AND PREVENT RELAPSE FOR LIFE
CHRONIC VIRAL INFECTIONS, WHERE OUR BEE CELLS UNDERGO CLASS SWITCHING AND SOMATIC HYPERMUTATION TO COMBAT RAPIDLY MUTATING VIRUSES
ACUTE MRSA BACTERIAL INFECTIONS, WHERE OUR BEE-CELLS OFFER PROPHYLACTIC PROTECTION FOR HIGH-RISK PATIENTS
NEURODEGENERATIVE DISEASES, WHERE OUR BEE-CELLS IDENTIFY AND RESOLVE THREATS BEFORE SYMPTOMS OCCUR
WE INTRODUCE CUSTOM ANTIBODIES INTO THE ENDOGENOUS LOCUS, MAKING OUR APPROACH APPLICABLE TO ANY TARGET
COMPATIBLE WITH ADDITIONAL BINDING DOMAINS: OUR BBB-SHUTTLE, LINKED ANTIBODY CHAINS FOR SIMPLFIED ENGENEERING OR ANTIBODY DERIVATES
WITH GREAT POWER COMES GREAT RESPONSIBILITY. THAT’S WHY OUR PLATFORM COMES WITH ADDITIONAL SAFETY FEATURES
FOR THIS WE IMPLEMENT A CASCADE SAFETY MECHANISM: KILL SWITCH, DEPLETION FACTOR, MODULATION SWITCH, AND OVER-EXPRESSION MARKER
EXPLORE THIS WIKI TO LEARN HOW WE PLAN TO MAKE THESE SKETCHES REALITY.
To view the homepage experience, please use screen above 1024px e.g. an iPad. You can still check out the rest of the website though!
A joint team from the Technical University of Munich and the Ludwig-Maximillians-University Munich.
© 2023 - Content on this site is licensed under a Creative Commons Attribution 4.0 International license.
The repository used to create this website is available at https://gitlab.igem.org/2023/munich
A joint team from the Technical University of Munich and the Ludwig-Maximillians-University Munich.
© 2023 - Content on this site is licensed under a Creative Commons Attribution 4.0 International license.
The repository used to create this website is available at https://gitlab.igem.org/2023/munich